NasdaqGS - Nasdaq Real Time Price USD

Amedisys, Inc. (AMED)

91.87

-0.11

(-0.12%)

As of 11:24:21 AM EST. Market Open.

UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through

UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.

Zacks 6 days ago

UNH

AMED
-0.12%
UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring

Health insurer United Health and Amedisys had been in talks for a $3.3 billion merger. In November, the Justice Department filed an antitrust lawsuit to block that merger.

The Wall Street Journal 6 days ago

AMED
-0.12%
UNH
UnitedHealth, Amedisys delay close date of $3.3B merger

The massive healthcare company and the home health provider have agreed to push back the timeline of their deal after the Department of Justice sued to block it.

Healthcare Dive 8 days ago

UNH

AMED
-0.12%
Company News for Dec 30, 2024

Companies In The News Are: AMED, UNH, LW, RGTI, COST.

Zacks 16 days ago

AMED
-0.12%
LW
Reasons to Retain AMED Stock in Your Portfolio Now

Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

Zacks 16 days ago

AMED
-0.12%
OMCL
+1.77%
RMD
UnitedHealth, Amedisys waive right to terminate merger pact

In a regulatory filing, Amedisys (AMED) stated, “As previously disclosed, on June 26, 2023, Amedisys, UnitedHealth Group (UNH), and Aurora Holdings Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of UnitedHealth Group, entered into an Agreement and Plan of Merger, pursuant to which Merger Sub will merge with and into Amedisys upon the terms and subject to the conditions set forth in the Merger Agreement, with Amedisys surviving the Merger as a wholly owned subsidiary of Unite

TipRanks 18 days ago

AMED
-0.12%
UNH
Update: UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny

(Updates to include UnitedHealth's response in the seventh paragraph.) UnitedHealth Group (UNH) a

PREMIUM
MT Newswires 18 days ago

UNH

AMED
-0.12%
Top Stock Movers Now: Lamb Weston, Amedisys, Supermicro, and More

Major U.S. indexes slumped at midday Friday as tech stocks lost ground.

Investopedia 18 days ago

SMCI

LW

AMED
-0.12%
Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal

Amedisys stock climbed Friday after the provider of home health care agreed to waive its right to terminate a merger agreement with UnitedHealth Group, bolstering expectations that the deal will succeed despite a government attempt to block it. Shares of Amedisys were up 4.7% to $89.97, marking a fifth consecutive days of gains. Amedisys agreed to be acquired for $3.3 billion, or $101 a share in cash, in June 2023, but the Justice Department filed a civil antitrust lawsuit last month, saying the proposal would eliminate competition in the hospice industry.

Barrons.com 18 days ago

UNH

AMED
-0.12%
Top Midday Gainers

Vaxart (VXRT) said on Friday it secured a $4.6 million increase in funding under a project agreement

PREMIUM
MT Newswires 18 days ago

GDYN

VXRT

AMED
-0.12%
Top Midday Stories: UnitedHealth, Amedisys Extend Deal-Close Deadline; OpenAI Mulling a For-Profit Structure

All three major US stock indexes were down more than 1% in late-morning trading Friday, as the marke

PREMIUM
MT Newswires 18 days ago

AMED
-0.12%
UNH

MSFT
UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny

UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline of their proposed merger

PREMIUM
MT Newswires 18 days ago

AMED
-0.12%
UNH
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger

UnitedHealth Group and Amedisys agreed to extend the deadline to complete their $3.3 billion merger, after the Department of Justice moved to block the deal.

Investopedia 18 days ago

AMED
-0.12%
UNH
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?

Amedisys Inc (NASDAQ:AMED) shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated (NYSE:UNH). In an exchange filing, the companies entered into a waiver agreement, further advancing their merger deal, originally announced on June 26, 2023. Under the terms of the agreement, Merger Sub, a wholly owned subsidiary of UnitedHealth, will merge with Amedisys, with Amedisys continuing to operate as a subsidiary of UnitedHealth

Benzinga 19 days ago

AMED
-0.12%
UNH
UnitedHealth's $3.3B Merger Drama: New Deadline, DOJ Pushback, and Big Risks for Investors

Regulators aren't backing down--what's next for UnitedHealth and Amedisys as the clock resets to 2025?

GuruFocus.com 19 days ago

UNH

AMED
-0.12%
UnitedHealth, Amedisys Extend Window to Complete Deal

(Bloomberg) -- UnitedHealth Group Inc. and Amedisys Inc. gave themselves more time to complete a $3.3 billion deal for the insurer to purchase the home-health provider that’s been challenged by the government. Most Read from BloombergMigrant Crisis Pushed US Homelessness to Record High in 2024The companies each waived their right to terminate the deal if it hadn’t been completed within an agreed-upon time, according to a filing Friday. Those dates were either 10 days after a court ruling on a US

Bloomberg 19 days ago

UNH

AMED
-0.12%
Merger Drama: UnitedHealth-Amedisys Waive Termination Rights, Face DOJ Hurdles with Extended Deal

UnitedHealth and Amedisys extend merger agreement to late 2025 amid legal challenges and DOJ lawsuit concerns

GuruFocus.com 19 days ago

UNH

AMED
-0.12%
UnitedHealth, Amedisys extend deadline to close $3.3 billion deal

The extension comes more than a month after the DOJ and three U.S. states filed a lawsuit to block the deal, citing concerns that it would reduce competition in the home health services market. The companies have entered into a new waiver agreement, which extends the merger deadline to 10 days after a final court decision is issued in the lawsuit or Dec. 31, 2025, whichever is earlier, the filing said. Shares of Amedisys rose 3.5% in premarket trading.

Reuters 19 days ago

UNH

AMED
-0.12%
Do Options Traders Know Something About Amedisys (AMED) Stock We Don't?

Investors need to pay close attention to Amedisys (AMED) stock based on the movements in the options market lately.

Zacks 22 days ago

AMED
-0.12%
Amedisys (AMED) Down 12.4% Since Last Earnings Report: Can It Rebound?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

AMED
-0.12%
CHE
+1.40%

Performance Overview

Return	AMED	S&P 500
YTD	+1.53%	+0.42%
1-Year	-2.56%	+24.00%
3-Year	-37.41%	+27.21%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Amedisys, Inc. (AMED)

UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through

UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring

UnitedHealth, Amedisys delay close date of $3.3B merger

Company News for Dec 30, 2024

Reasons to Retain AMED Stock in Your Portfolio Now

UnitedHealth, Amedisys waive right to terminate merger pact

Update: UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny

Top Stock Movers Now: Lamb Weston, Amedisys, Supermicro, and More

Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal

Top Midday Gainers

Top Midday Stories: UnitedHealth, Amedisys Extend Deal-Close Deadline; OpenAI Mulling a For-Profit Structure

UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny

Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger

Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?

UnitedHealth's $3.3B Merger Drama: New Deadline, DOJ Pushback, and Big Risks for Investors

UnitedHealth, Amedisys Extend Window to Complete Deal

Merger Drama: UnitedHealth-Amedisys Waive Termination Rights, Face DOJ Hurdles with Extended Deal

UnitedHealth, Amedisys extend deadline to close $3.3 billion deal

Do Options Traders Know Something About Amedisys (AMED) Stock We Don't?

Amedisys (AMED) Down 12.4% Since Last Earnings Report: Can It Rebound?

Performance Overview